Thalys Medical Technology Group Inc.

Shanghai Stock Exchange 603716.SS

Thalys Medical Technology Group Inc. Net Income Margin for the year ending December 31, 2023: -7.90%

Thalys Medical Technology Group Inc. Net Income Margin is -7.90% for the year ending December 31, 2023, a 4.59% change year over year. Net Income Ratio, also known as the profit margin, is the ratio of net income to net sales, showing the percentage of revenue that remains as profit after all expenses are deducted.

Thalys Medical Technology Group Inc. Net Income Margin for the year ending December 31, 2022 was -8.28%, a -461.15% change year over year.
Thalys Medical Technology Group Inc. Net Income Margin for the year ending December 31, 2021 was -1.48%, a -138.25% change year over year.
Thalys Medical Technology Group Inc. Net Income Margin for the year ending December 31, 2020 was 3.86%, a -36.01% change year over year.
Thalys Medical Technology Group Inc. Net Income Margin for the year ending December 31, 2019 was 6.03%, a -15.61% change year over year.

Key data

Date	Net Income Margin	EBITDA Margin	EBIT Margin	EBITDA

Shanghai Stock Exchange: 603716.SS

Thalys Medical Technology Group Inc.

CEO	Mr. Zheng Wang
IPO Date	Oct. 31, 2016
Location	China
Headquarters	1310 Jinshan Avenue
Employees	1,406
Sector	Health Care
Industries Pharmaceuticals Hospitals & Clinics

Description

Thalys Medical Technology Group Inc. engages in the medical intensive business and operation services in China. The company was formerly known as Thalys Medical Technology Inc. and changed its name to Thalys Medical Technology Group Inc. in September 2020. Thalys Medical Technology Group Inc. was founded in 2004 and is headquartered in Wuhan, China.

Key trends

Past 5 years